House dust endotoxin, asthma and allergic sensitization through childhood into adolescence.

Publication Year: 2020

DOI:
10.1111/cea.13705

PMCID:
PMC7540017

PMID:
32640057

Journal Information

Full Title: Clin Exp Allergy

Abbreviation: Clin Exp Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST Gerard H. Koppelman reports research grants from the Lung Foundation of the Netherlands for the work presented in this manuscript and has received funding from TETRI Foundation, UBBO EMMIUS Foundation, TEVA the Netherlands, VERTEX, GSK, the European Union (H2020) for research outside the submitted work; he has participated in advisory board meetings of GSK and PURE‐IMS (outside the current work)."

Evidence found in paper:

"The authors would like to thank PIAMA participants and parents who contributed to the study and Marjan Tewis for data management. The research leading to these results has received funding from Dutch Lung Foundation (Project number 4.1.14.001). In addition, the PIAMA study was supported by The Netherlands Organization for Health Research and Development; The Netherlands Organization for Scientific Research; The Netherlands Asthma Fund; The Netherlands Ministry of Spatial Planning, Housing, and the Environment; and The Netherlands Ministry of Health, Welfare, and Sport. Ulrike Gehring was supported by a Grant of The Netherlands Organization for Scientific Research. Gerard H. Koppelman reports research grants from the Lung Foundation of the Netherlands for the work presented in this manuscript and has received funding from TETRI Foundation, UBBO EMMIUS Foundation, TEVA the Netherlands, VERTEX, GSK, the European Union (H2020) for research outside the submitted work; he has participated in advisory board meetings of GSK and PURE‐IMS (outside the current work)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025